4[4]Eisenkop S M,Triendman R L,Wang H J.Secondry Cytoreductive surgery for recurrent ovarian cancer[J].Cancer,1995,76:1605-1614.
5[6]Kenemans P,Yedema C A,Bon C G,et al.CA125 in gynerecologic patnologe review[J].Eur J Obstet and Reprod Biol,1993,49:145.
6[7]Robert P W,Mark P C,Fengji X,et al.Combinations of multiple serum markers are superior to indiridual assays for discriminiating malignant from benign pelvicmasses[J].Gynecol Oncol,1995,59:111-116.
7[10]Vander,Zee A G,Guk J M.The effect of abdominal surgery on the serum concertration of the tumor associated antigen CA125[J].Br J Obstet Gynecol,1990,97:934.
8[13]Low R N,Saleh F,Song S,et al.Treated ovarian caner:Comparison of MR image with serum CA125 level and physical examination-a longitudinal study[J].Radiology,1999,211:519-528.
9[17]Vander B M,Lammes F B,Vanputten W L J,et al.The prognostic value of the serum half-time of CA125 during the induction of chemotherapy[J].Gynecol Oncol,1988,39(6):307.
10[18]Hogberg T,Kagedal B.Long-term follow-up of ovarian cancer with monthly determinations of serum CA125[J].Gynecol Oncol,1992,46:191-198.
